/Companies

Inspirna

New York, US · 9 known investors

Find your way into Inspirna

Sign up to see every warm intro you have to Inspirna

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Inspirna team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Inspirna is a clinical-stage biopharmaceutical company developing novel cancer drugs that target previously undruggable drivers of metastasis using its proprietary miRNA-DRIVEr platform. The company focuses on common cancers with high unmet need through small molecules and biologics.

Founders & leadership

ST
Sohail TavazoieCo-Founder & Chair of Scientific Advisory Board
MT
Masoud TavazoieCo-Founder & Advisor

Investors · 9

Also in the syndicate · 4

Dreavent 6Lepu HoldingsNew York City Investment Fund LLCSixty Degree Capital Fund

Funding

SEC filings, press & company announcements

$50M disclosed across 1 of 2 rounds · 2022

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Frequently asked questions

What does Inspirna do?
Inspirna is a clinical-stage biopharmaceutical company developing novel cancer drugs that target previously undruggable drivers of metastasis using its proprietary miRNA-DRIVEr platform. The company focuses on common cancers with high unmet need through small molecules and biologics.
Who founded Inspirna?
Inspirna was founded by Sohail Tavazoie, Masoud Tavazoie.
Who are Inspirna's investors?
Inspirna's investors include Sofinnova Partners, Vivo Capital, Sands Capital Ventures, Start Capital, Novo Holdings.
How much funding has Inspirna raised?
Inspirna has disclosed $50M raised across 1 of its 2 known rounds.
Where is Inspirna headquartered?
Inspirna is headquartered in New York, US.